Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma

CA 19–9 is an extremely useful biomarker for pancreatic ductal adenocarcinomas (PDACs). However, the optimal cut-off and prognostic significance at higher cut-offs are yet to be determined. Retrospective analysis included patients with PDAC who underwent curative resection from January 2010 to May 2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HPB (Oxford, England) England), 2024-10, Vol.26 (10), p.1237-1247
Hauptverfasser:	Bhandare, Manish S., Gupta, Vikas, Chaudhari, Vikram, Nandy, Kunal, Ostwal, Vikas, Ramaswamy, Anant, Nashikkar, Chaitali, Engineer, Reena, Krishnatry, Rahul, Shrikhande, Shailesh V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biomarkers, Tumor - blood CA-19-9 Antigen - blood Carcinoma, Pancreatic Ductal - blood Carcinoma, Pancreatic Ductal - mortality Carcinoma, Pancreatic Ductal - surgery Female Humans Male Middle Aged Neoadjuvant Therapy Pancreatectomy Pancreatic Neoplasms - blood Pancreatic Neoplasms - mortality Pancreatic Neoplasms - surgery Predictive Value of Tests Prognosis Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!